Novozymes A/S (NVZMY)
OTC: NVZMY
· Real-Time Price · USD
65.22
-0.62 (-0.94%)
At close: Aug 14, 2025, 3:59 PM
65.23
0.02%
Pre-market: Aug 15, 2025, 08:38 AM EDT
Novozymes A/S Cash Flow Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 904.55M | 1.41B | 2.1B | 2.48B | 3.04B | 3.22B | 3.44B | 3.65B | 3.69B | 3.43B | 3.12B | 3.1B | 3.15B | 3.18B | 3.04B | 2.9B |
Depreciation & Amortization | n/a | 263M | 595M | 930M | 1.29B | 1.39B | 1.44B | 1.48B | 1.49B | 1.46B | 1.44B | 1.44B | 1.42B | 2.23B | 1.88B | 1.5B |
Stock-Based Compensation | n/a | 152M | 152M | 152M | 152M | 102M | 102M | 102M | 102M | 111M | 111M | 111M | 111M | 62M | 62M | 62M |
Other Working Capital | 1.27B | 1.74B | 1.65B | 932.8M | 213M | -5M | 3M | -11M | -452M | -280M | -462M | -188M | -56M | -6M | -45M | 79M |
Other Non-Cash Items | 2.37B | 2.35B | 2.28B | 1.38B | 416M | -71M | -373M | -243M | 149M | 493M | 1.29B | 1.6B | 1.53B | 1.54B | 1.28B | 1.22B |
Deferred Income Tax | n/a | -576M | -576M | -576M | -576M | -472M | -472M | -472M | -472M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.27B | 1.95B | 2.1B | 1.44B | -166M | -560M | -893M | -971M | -583M | -562M | -780M | -762M | -612M | -303M | -124M | 179M |
Operating Cash Flow | 4.54B | 5.55B | 6.65B | 5.81B | 4.15B | 3.61B | 3.25B | 3.54B | 4.01B | 4.12B | 4.01B | 3.94B | 4.06B | 4.41B | 4.2B | 4.29B |
Capital Expenditures | -1.28B | -1.82B | -2.09B | -2.13B | -2.06B | -2.35B | -2.63B | -2.93B | -2.89B | -2.59B | -2.06B | -1.44B | -1.24B | -985M | -988M | -997M |
Cash Acquisitions | 179.88M | 102.88M | 25.38M | -189.31M | -158M | -79M | 199M | 335M | 192M | -680M | -946M | -932M | -1.63B | -763M | -765M | -1.34B |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 484.5M | 555.4M | 525.6M | 284.8M | 43M | 164M | 227M | 194M | 194M | 116M | 92M | 124M | 124M | 4M | 5M | 5M |
Investing Cash Flow | -592.61M | -1.16B | -1.5B | -2B | -2.13B | -2.43B | -2.41B | -2.57B | -2.67B | -3.12B | -2.88B | -2.24B | -2.75B | -1.75B | -1.75B | -2.33B |
Debt Repayment | -491.8M | -24.3M | -760M | -815.3M | 717M | 169M | 722M | 809M | 325M | 1.03B | 777M | 610M | 576M | -122M | 273M | 531M |
Common Stock Repurchased | -30.8M | n/a | n/a | n/a | n/a | n/a | n/a | -360M | -500M | -500M | -868M | -1.36B | -1.5B | -1.5B | -1.71B | -1.5B |
Dividend Paid | -1.06B | -2.25B | -2.13B | -1.66B | -2.86B | -1.66B | -1.66B | -1.66B | -1.52B | -1.52B | -1.52B | -1.52B | -1.47B | -1.47B | -1.47B | -1.47B |
Other Financial Acitivies | -1.14B | -880.64M | 529.96M | 409.35M | 1.6B | 1.48B | 56.38M | 128M | 344M | 315M | 303M | 409M | 623M | 270M | 197M | 421M |
Financial Cash Flow | -1.91B | -2.37B | -3.01B | -2.08B | -1.89B | -1.31B | -748M | -959M | -1.25B | -581M | -1.16B | -1.7B | -1.59B | -2.64B | -2.46B | -1.78B |
Net Cash Flow | 466.15M | 437.65M | 545.45M | 79.1M | 75M | -202M | 35M | 3M | 78M | 514M | 44M | 34M | -218M | 7M | -55M | 137M |
Free Cash Flow | 3.26B | 3.73B | 4.56B | 3.68B | 2.1B | 1.26B | 615M | 617M | 1.12B | 1.53B | 1.95B | 2.5B | 2.82B | 3.43B | 3.21B | 3.29B |